Delivery Order SPE2DB22D2206-SPE2DB25FJG27
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Albutein 5% in 250ml vials, with a ceiling value of $1,128.50. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 16, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.65 to AmerisourceBergen Drug Corp for Albutein 5% vials (250ml) under a firm fixed price contract type, with an ultimate completion date of September 4, 2025. This non-set-aside award was issued on August 13, 2025, with performance to be completed in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,353.60 to AmerisourceBergen Drug Corp for Albutein 5% Vial 250ML on October 14, 2025, with an ultimate completion date of November 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location....
- The Defense Logistics Agency awarded a $1,131.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of ALBUKED-25 vial 50ML pharmaceutical product. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 1, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,320.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of ALBUKED-5 VIAL 250ML pharmaceutical products. The delivery order, which is a child action under a larger contract vehicle, has an ultimate completion date of August 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This non-competitive award reflects the ordering activity under an existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,368.90 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 vial 100ML on September 29, 2025, with an ultimate completion date of October 21, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a $1,980.90 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of ALBUKED-5 VIAL 250ML pharmaceutical products. This is a firm fixed price delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,140.75 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of ALBUKED-25 vials in 100ml quantities. This firm fixed-price contract, with an ultimate completion date of October 10, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the contractor's facility in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,281.50 by the Defense Logistics Agency on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract calls for the delivery of Albuked-25 vial 100ml to support federal medical procurement needs. The delivery order is classified as a child contract under a larger indefinite delivery contract vehicle, reflecting...
- The Defense Logistics Agency (DLA) awarded a $1,320.60 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Albuked-5 Vial 250ML, a pharmaceutical product. This is a firm fixed price contract with an ultimate completion date of October 7, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made without a set-aside designation through competitive procurement....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJG27Delivery Order
The Defense Logistics Agency awarded a $2,507.45 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Albutein 5% in 250mL vials. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse medical supply needs across multiple therapeutic domains, positioning it as a key vendor within the DLA's global pharmaceutical support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/6/25 |